ArticleIJID regions2026
Invasive meningococcal disease over five decades in the Faroe Islands: high incidence, low mortality, and implications for vaccination policy.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The Faroe Islands have previously experienced a very high incidence of meningococcal disease, with an epidemic beginning in the late 1970s followed by more than a decade of endemic transmission.To present a population-based epidemiological overview of invasive meningococcal disease (IMD) in the Faroe Islands from 1980 to 2025. Methods: Cases were identified through records from the Chief Medical Officer and hospital diagnosis registers. Clinical data were extracted from hospital records. Results: A total of 234 IMD cases were identified. Incidence peaked in 1981 at 100 per 100,000 population and declined gradually to 13 per 100,000 by 1990, remaining stable at 0-7 per 100,000 thereafter. Ninety-one percent of cases occurred in individuals under 20 years of age, with 53% in children aged ≤4 years. The case fatality rate was 5% in 1980-1986 and zero thereafter. The predominant serogroup was B, with a prevalence of 89% until 1984 followed by a decline to 77% in the following years (1985-2025). Conclusion: IMD in the Faroe Islands was characterized by an unusually high and prolonged incidence followed by a marked decline to low endemic levels, with consistently low mortality. Despite the current low incidence, the potential role of childhood meningococcal vaccination warrants further evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.